Page 7 of 8
The Journal of Organic Chemistry
3 using 4ꢀcyanobenzaldehyde hydrazone 3d (34.6 mg, 200 µmol,
(t, 6H). 19F NMR (282 MHz, CDCl3, 300 K) δ (ppm) = ꢀ81.2, ꢀ
1
2
3
4
5
6
7
8
1.00 equiv) and nonafluorobutyl iodide (105 µL, 600 µmol,
3.00 equiv). 6d was obtained as yellow solid (65.1 mg, 83%).
Spectral data are in accordance with literature reports.13 1H NMR
105.3, ꢀ120.1, ꢀ124.5.
(E)ꢀ1,1ꢀdimethylꢀ2ꢀ(2,2,3,3,4,4,5,5,5ꢀnonafluoroꢀ1ꢀ(4ꢀ
methoxyphenyl)pentylidene)hydrazine 6o. According to general
procedure 3 using 3o (35.7 mg, 200 µmol, 1.00 equiv) and noꢀ
nafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6o was
obtained as yellow oil (56.0 mg, 77%). Spectral data are in acꢀ
cordance with literature reports.13 1H NMR (600 MHz, CDCl3,
300 K): δ (ppm) = 7.23 (d, 3J = 8.7 Hz, 2H), 6.93 – 6.82 (m, 2H),
3.83 (s, 3H), 2.74 (s, 6H). 19F NMR (564 MHz, CDCl3, 300 K) δ
(ppm) = ꢀ81.19, ꢀ105.63, ꢀ120.07, ꢀ124.44.
3
(300 MHz, CDCl3, 300 K): δ (ppm) = 7.66 (d, J = 8.3 Hz, 2H),
7.44 (d, 3J = 8.3 Hz, 2H), 2.80 (s, 6H). 19F NMR (282 MHz,
CDCl3, 300 K) δ (ppm) = ꢀ81.2, ꢀ104.8, ꢀ120.2, ꢀ124.6.
Methyl
(E)ꢀ4ꢀ(1ꢀ(2,2ꢀdimethylhydrazono)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentyl)benzoate 6f. According to general procedure 3
using 3f (41.3 mg, 200 µmol, 1.00 equiv) and nonafluorobutyl
iodide (105 µL, 600 µmol, 3.00 equiv). 6f was obtained as yellow
solid (67.6 mg, 79%). 1H NMR (600 MHz, CDCl3, 300 K): δ
(ppm) = 8.07 – 7.97 (m, 2H), 7.42 – 7.37 (m, 2H), 3.93 (s, 3H),
2.77 (s, 6H). 13C{1H, 19F} NMR (151 MHz, CDCl3) δ (ppm) =
166.6, 130.6, 129.2, 126.1, 117.8, 114.0, 111.5, 109.2, 52.4, 46.8.
19F NMR (564 MHz, CDCl3, 300 K) δ (ppm) = ꢀ81.2, ꢀ105.0, ꢀ
120.1, ꢀ124.5. HRMS (ESI): calcd for [C15H13F9N2O2Na]+: m/z
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(E)ꢀ1,1ꢀdimethylꢀ2ꢀ(2,2,3,3,4,4,5,5,5ꢀnonafluoroꢀ1ꢀ
(naphthalenꢀ2ꢀyl)pentylidene)hydrazine 6p. According to general
procedure 3 using 3p (39.7 mg, 200 µmol, 1.00 equiv) and noꢀ
nafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6p was
obtained as yellow oil (38.4 mg, 46%). 1H NMR (600 MHz,
CDCl3, 300 K): δ (ppm) = 7.88 – 7.84 (m, 2H), 7.84 – 7.82 (m,
1H), 7.81 – 7.80 (m, 1H), 7.57 – 7.49 (m, 2H), 7.43 (m, 1H), 2.77
(s, 6H). 13C{1H, 19F} NMR (151 MHz, CDCl3) δ (ppm) = 133.1,
132.4, 129.8, 129.7, 128.3, 128.1, 127.7, 127.5, 127.3, 127.0,
126.6, 117.7, 114.0, 111.4, 109.1, 46.6. 19F NMR (564 MHz,
CDCl3, 300 K) δ (ppm) = ꢀ81.1, ꢀ105.0, ꢀ119.9, ꢀ124.4. HRMS
(ESI): calcd for [C17H13F9N2H]+: m/z = 417.1013; found: m/z =
417.0999, calcd for [C17H13F9N2Na]+: m/z = 439.0833; found:
m/z = 439.0822.
=
447.0731; found: m/z
=
447.0742, calcd for
[(C15H13F9N2O2)Na]+: m/z = 871.1564; found: m/z = 871.1562.
Mp 26ꢀ27 °C.
(E)ꢀ4ꢀ(1ꢀ(2,2ꢀdimethylhydrazono)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentyl)ꢀN,Nꢀdimethylaniline 6h. According to general
procedure 3 using 3h (38.3 mg, 200 µmol, 1.00 equiv) and noꢀ
nafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6h was
obtained as yellow solid (38.2 mg, 47%). 1H NMR (300 MHz,
3
3
CDCl3, 300 K): δ (ppm) = 7.16 (d, J = 8.9 Hz, 2H), 6.66 (d, J =
8.9 Hz, 2H), 2.99 (s, 6H), 2.73 (s, 6H). 13C{1H, 19F} NMR
(151 MHz, CDCl3) δ (ppm) = 19F NMR (564 MHz, CDCl3,
300 K) δ (ppm) = ꢀ81.2, ꢀ105.8, ꢀ120.0, ꢀ124.4. HRMS (ESI):
calcd for [C15H16F9N3H]+: m/z = 410.1279; found: m/z =
410.1276, calcd for [C15H16F9N3Na]+: m/z = 432.1098; found:
m/z = 432.1095.
1,4ꢀBis((E)ꢀ1ꢀ(2,2ꢀdimethylhydrazono)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentyl)benzene 6q. According to general procedure 3
using 3q (43.7 mg, 200 µmol, 1.00 equiv) and nonafluorobutyl
iodide (105 µL, 600 µmol, 3.00 equiv). 6q was obtained as yellow
solid (48.0 mg, 37%). 1H NMR (600 MHz, CDCl3, 300 K): δ
(ppm) = 7.31 (s, 4H), 2.76 (s, 12H).13C{1H, 19F} NMR (151 MHz,
CDCl3) δ (ppm) = 133.2, 129.8, 126.7, 117.6, 113.8, 111.3, 109.0,
46.5.19F NMR (564 MHz, CDCl3, 300 K) δ (ppm) = ꢀ81.2, ꢀ105.3,
ꢀ120.1, ꢀ124.5. HRMS (ESI): calcd for [C20H16F18N4Na]+: m/z
= 677.0985; found: m/z = 677.0989. Mp: 63ꢀ64 °C.
(E)ꢀ2ꢀ(1ꢀ(4ꢀ(tertꢀbutyl)phenyl)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentylidene)ꢀ1,1ꢀdimethylhydrazine 6j. According to
general procedure 3 using 3j (40.9 mg, 200 µmol, 1.00 equiv) and
nonafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6j was
obtained as yellow solid (61.6 mg, 73%). 1H NMR (300 MHz,
CDCl3, 300 K): δ (ppm) = 7.41 – 7.31 (m, 2H), 7.28 – 7.19 (m,
2H), 2.73 (s, 6H), 1.33 (s, 6H). 13C{1H, 19F} NMR (151 MHz,
CDCl3) δ (ppm) = 152.2, 129.8, 129.1, 129.0, 124.8, 117.7, 113.9,
111.4, 109.1, 46.4, 42.7, 34.7, 31.2. 19F NMR (282 MHz, CDCl3,
300 K) δ (ppm) = ꢀ81.2, ꢀ105.3, ꢀ120.0, ꢀ124.4. HRMS (ESI):
calcd for [C17H19F9N2Na]+: m/z = 445.1302; found: m/z =
445.1307. Mp: 25ꢀ27 °C.
(E)ꢀ1,1ꢀdimethylꢀ2ꢀ(2,2,3,3,4,4,5,5,5ꢀnonafluoroꢀ1ꢀ(oꢀ
tolyl)pentylidene)hydrazine 6r. According to general procedure 3
using 3r (32.5 mg, 200 µmol, 1.00 equiv) and nonafluorobutyl
iodide (105 µL, 600 µmol, 3.00 equiv). 6r was obtained as yellow
1
oil (32.8 mg, 37%). H NMR (600 MHz, CDCl3, 300 K): δ (ppm)
3
4
3
= 7.28 (td, J = 7.5 Hz, J = 1.5 Hz, 1H), 7.25 (d, J = 7.5 Hz,
1H), 7.22 – 7.17 (m, 1H), 7.19 – 7.13 (m, 1H), 2.72 (s, 6H), 2.24
(s, 3H). 13C{1H, 19F} NMR (151 MHz, CDCl3) δ (ppm) = 138.9,
131.9, 130.5, 129.5, 129.3, 127.8, 125.0, 117.7, 114.3, 111.5,
109.1, 45.7, 19.8. 19F NMR (564 MHz, CDCl3, 300 K) δ (ppm)
(E)ꢀ2ꢀ(1ꢀ(benzo[d][1,3]dioxolꢀ5ꢀyl)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentylidene)ꢀ1,1ꢀdimethylhydrazine 6l. According to
general procedure 3 using 3l (38.4 mg, 200 µmol, 1.00 equiv) and
nonafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6l was
obtained as yellow oil (52.6 mg, 73%). 1H NMR (600 MHz,
CDCl3, 300 K): δ (ppm) = 6.85 – 6.71 (m, 3H), 6.00 (s, 2H), 2.78
(s, 6H). 13C{1H, 19F} NMR (151 MHz, CDCl3) δ (ppm) = 148.3,
147.4, 128.0, 125.5, 124.55, 117.8, 114.0, 111.6, 110.6, 109.2,
108.0, 101.5, 46.5. 19F NMR (564 MHz, CDCl3, 300 K) δ (ppm)
=
ꢀ81.2, ꢀ104.8, ꢀ119.7, ꢀ123.9. HRMS (ESI): calcd for
[C14H13F9N2H]+: m/z = 381.1013; found: m/z = 381.1009, calcd
for [C14H13F9N2Na]+: m/z = 403.0833; found: m/z = 403.0824.
(E)ꢀ1,1ꢀdimethylꢀ2ꢀ(2,2,3,3,4,4,5,5,6,6,7,7,7ꢀtridecafluoroꢀ1ꢀ
phenylheptylidene)hydrazine 6s. According to general procedure 3
using 3a (33 µL, 0.20 mmol, 1.0 equiv) and perfluorohexyl iodide
(130 µL, 600 µmol, 3.00 equiv). 6s was obtained as orange oil
1
(81.4 mg, 87%). H NMR (600 MHz, CDCl3, 300 K): δ (ppm) =
7.39 – 7.32 (m, 3H), 7.34 – 7.29 (m, 2H), 2.74 (s, 6H). 13C{1H,
19F} NMR (151 MHz, CDCl3) δ (ppm) = 132.5, 130.5, 129.2,
128.5, 128.1, 118.4, 116.5, 114.1, 111.5, 110.6, 108.9, 108.6,
46.6. 19F NMR (564 MHz, CDCl3, 300 K) δ (ppm) = ꢀ80.9, ꢀ
105.2, ꢀ119.3, ꢀ120.5, ꢀ122.8, ꢀ126.1. HRMS (ESI): calcd for
[C15H11F13N2Na]+: m/z = 489.0612; found: m/z = 489.0619.
=
ꢀ81.2, ꢀ105.4, ꢀ120.0, ꢀ124.4. HRMS (ESI): calcd for
[C14H11F9N2O2H]+: m/z = 411.0755; found: m/z = 411.0627,
calcd for [C14H11F9N2O2Na]+: m/z = 433.0575; found: m/z =
433.0566.
(E)ꢀ2ꢀ(1ꢀ(4ꢀchlorophenyl)ꢀ2,2,3,3,4,4,5,5,5ꢀ
nonafluoropentylidene)ꢀ1,1ꢀdimethylhydrazine 6n. According to
general procedure 3 using 3n (36.5 mg, 200 µmol, 1.00 equiv)
and nonafluorobutyl iodide (105 µL, 600 µmol, 3.00 equiv). 6n
was obtained as yellow oil (63.9 mg, 80%). Spectral data are in
accordance with literature reports.13 1H NMR (300 MHz, CDCl3,
300 K): δ (ppm) = 7.40 – 7.29 (m, 2H), 7.28 – 7.28 (m, 2H), 2.77
(E)ꢀ2ꢀ(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9ꢀheptadecafluoroꢀ1ꢀ
phenylnonylidene)ꢀ1,1ꢀdimethylhydrazine 6t. According to genꢀ
eral procedure 3 using 3a (33 µL, 0.20 mmol, 1.0 equiv) and
perfluorooctyl iodide (160 µL, 600 µmol, 3.00 equiv). 6t was
obtained as orange oil (97.1 mg, 86%). 1H NMR (600 MHz,
CDCl3, 300 K): δ (ppm) = 7.39 – 7.33 (m, 3H), 7.33 – 7.28 (m,
ACS Paragon Plus Environment